Vijaypd Ceutical IPO Details
The key details of Vijaypd Ceutical’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹19.25 Cr |
| Price Range | ₹35 |
| Retail Quota | 50% |
| QIB Quota | -- |
| NII Quota | 50% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 8,000 |
| Investment (cut-off price) | ₹2,80,000 |
| Pre IPO Promotor Holding | 78.30% |
| Post IPO Promotor Holding | 56.25% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Vijaypd Ceutical IPO Timelines
The IPO process for Vijaypd Ceutical includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
29/09/2025
Start Date01/10/2025
End Date06/10/2025
Refund Initiation06/10/2025
Credit of Shares to Demat Ac07/10/2025
Listing DateVijaypd Ceutical IPO Lot Size
The Vijaypd Ceutical IPO has a fixed lot size of 4,000 shares, at a fixed price band of ₹35 per share. For retail investors, the minimum and maximum application is 8,000 shares (2 lots) amounting to ₹2,80,000. For HNI investors, the minimum application is 12,000 shares (3 lots) worth ₹4,20,000.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 8000 | ₹2,80,000 |
| Retail Maximum | 2 | 8000 | ₹2,80,000 |
| HNI Minimum | 3 | 12000 | ₹4,20,000 |
Vijaypd Ceutical IPO Subscription Status
The subscription status for Vijaypd Ceutical IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| -- | 1.86x | 0.87x | -- | 1.36x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹ | ₹ | ₹ | ₹ |
Vijaypd Ceutical IPO Company Financials
Vijaypd Ceutical reports robust performance in FY2025 with Total Income of ₹107.59 crores, managing expenses at ₹101.06 crores, and achieving a strong PAT (Profit After Tax) of ₹4.80 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2023 | ₹50.59 | ₹50.24 | ₹0.18 |
| FY 2024 | ₹54.34 | ₹51.56 | ₹1.65 |
| FY 2025 | ₹107.59 | ₹101.06 | ₹4.80 |
About Company
Incorporated in October 1971, Vijaypd Ceutical Limited is engaged in the distribution of pharmaceutical products and consumer goods, serving the pharmaceutical, wellness, and FMCG sectors. The company operates as a representative, dealer, agent, stockist, supplier, trader, and packer, offering a wide range of products including injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral medicines, vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, and ayurvedic items. It also distributes personal care products such as soaps, sanitizers, baby care goods, along with cosmetics, food products, dental supplies, and crude drugs.
As of March 31, 2025, Vijaypd Ceutical Limited serves over 2,109 pharmacies, clinics, and nursing homes across 20 locations in four districts. Its extensive distribution network connects with more than 170 healthcare product manufacturers and provides access to over 19,000 stock keeping units. This robust product portfolio allows the company to meet a wide range of customer needs with a strong focus on quality and reliability. The company is certified by the FDA, FSSAI, and BMC, reinforcing its commitment to regulatory compliance and trusted pharmaceutical supply.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 1971 | Pharmaceuticals | Samit Shah |
Know Before Investing
Vijaypd Ceutical IPO Strengths
- Vijaypd Ceutical, founded in 1971, has over five decades of experience as a trusted pharmaceutical and consumer goods distributor, with strong brand recognition in Western Mumbai and surrounding regions.
- Offers a wide array of healthcare products including medicines (injections, tablets, capsules), wellness items, ayurvedic products, cosmetics, personal care, and FMCG items, catering to diverse customer needs.
- The company serves over 2,100 pharmacies, clinics, and nursing homes, benefiting from long-standing, loyal ties ensuring steady revenue and repeat business.
- Operates three well-located warehouses with robust last-mile delivery infrastructure enabling timely and efficient product delivery across its service areas.
- Uses advanced inventory management and cold chain technology to maintain product quality and reduce wastage, vital in pharmaceuticals distribution.
Vijaypd Ceutical IPO Risks
- Significant revenues are derived from Maharashtra, especially Mumbai and surrounding districts, increasing sensitivity to regional economic conditions and regulatory changes.
- Potential losses and reputational damage may arise from returns of expired, defective, or counterfeit products and claims related to product safety or handling.
- Dependence on timely procurement from over 150 manufacturers and managing a complex portfolio of over 24,000 SKUs raise risks of stock-outs and inventory obsolescence.
- Historical negative cash flows may present challenges in liquidity management, impacting working capital and growth plans.
- Depends on healthcare product manufacturers for supply continuity and product quality affects the company’s market standing.
Swot Analysis for Vijaypd Ceutical IPO
Strengths
Long Industry Experience, Robust Distribution Network, Efficient Inventory Management & Cold Chain
Weaknesses
Geographical Concentration Risk, High Working Capital Requirement, Dependence on Multiple Suppliers
Opportunities
Geographical Expansion, Growing Demand for Wellness Products, Digital Platforms Adoption
Threats
Intense Competition, Regulatory Compliance Risks, Product Liability and Recall Risks
Company Details
Vijaypd Ceutical Ltd.
A/1, 1st Floor, Devraj Premises, CHSL, Goregaon West, Mumbai – 400062, Maharashtra, India.
Phone: +91 9820917040
Email: investors@vijaypdceutical.com
Website: https://www.vijaypdceutical.com/
IPO Registar Details
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: vcl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
FAQs
The key objectives of Vijaypd Ceutical SME IPO are:
- Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra
- Repayment/prepayment of all or certain of the borrowings availed of by the Company
- General corporate purposes
Smart Horizon Capital Advisors Pvt. Ltd. is the book-running lead managers for the Vijaypd Ceutical IPO.
Vijaypd Ceutical IPO shows strong growth potential with revenue doubling to ₹107.59 crore and profit rising to ₹4.80 crore in FY25. Its diversified portfolio in pharmaceuticals and FMCG, combined with over 50 years of industry presence, positions it well for expansion and credibility-driven market growth.
The issue price for the Vijaypd Ceutical IPO is set to ₹35 per share.
To invest in two lot of Vijaypd Ceutical IPO, you need ₹2,80,000 at the fixed price band (₹35 per share) for a lot size of 8000 shares.
Vijaypd Ceutical IPO shares are scheduled to be listed on the National Stock Exchange (NSE) on October 7, 2025.
Refund/unblocking of funds for Vijaypd Ceutical IPO will begin on October 6, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Vijaypd Ceutical IPO shares on listing day (October 7, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.